Abdullahi S.H.,Uzairu A.,Shallangwa G.A.,Uba S.,Umar A.B. .2022 .Computational modeling, ligand-based drug design, drug-likeness and ADMET properties studies of series of chromen2-ones analogues as anti-cancer agents. Bull. Nat. Res, 46 : 177.
Adelusi T.I.,Oyedele A.Q.K.,Boyenle I.D.,Ogunlana A.T.,Adeyemi R.O.,Ukachi C.D.,Idris M.O.,Olaoba O.T.,Adedotun I.O.,Kolawole O.E.,Xiaoxing Y. .2022 .Molecular modeling in drug discovery. Inf. Med, 29 : 100880.
Bamidele J.O.,Ambrose G.O.,Alakanse O.S. .2020 .Selection of oxypeucedanin as a potential antagonist from molecular docking analysis of HSP90. -0136, 7 : 867-875.
Ding Y.,Zhen Z.,Nisar M. A.,Ali F.,Din R. U.,Khan M.,Mughal T. A.,Alam G.,Liu L.,Saleem M.Z. .2022 .Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 Axis and P-glycoprotein transporters in lung cancer cells. Front. Pharmacol., 13 : 795613.
Dong L.,He J.,Luo L.,Wang K. .2023 .Targeting the interplay of autophagy and ROS for cancer therapy: An updated overview on phytochemicals. Pharmaceuticals, 16 : 92.
Gul S.,Muhammad S.,Irfan M.,Belali T.M.,Chaudhry A.R.,Khan M. .2024 .Discovery of potential natural STAT3 inhibitors: An in silico molecular docking and molecular dynamics study. J. Comput. Biophys. Chem, 23 : 189-205.
Harini M.,Kavitha K.,Prabakaran V.,Krithika A.,Dinesh S.,Rajalakshmi A.,Suresh G.,Puvanakrishnan R.,Ramesh B. .2024 .Identification of apigenin-4'-glucoside as bacterial DNA gyrase inhibitor by QSAR modeling, molecular docking, DFT, molecular dynamics, and in vitro confirmation studies. J. mol. Model, 30 : 1-14.
Ilyas M.,Muhammad S.,Iqbal J.,Amin S.,Al-Sehemi A. G.,Algarni H.,Alarfaji S.S.,Alshahrani S.S.,Ayub K. .2022 .Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19. , 76 : 6271-6285.
Jumper J.,Evans R.,Pritzel A.,Green T.,Figurnov M.,Ronneberger K.,Bates R.,Žídek A.,Potapenko A.,Bridgland A.,Hassabis D. .2021 .Highly accurate protein structure prediction with AlphaFold. Nature, 596 : 583-589.
Khan M.,Maryam A.,Saleem M.Z.,Shakir H.A.,Qazi J.I.,Li Y. .2020 .Brevilin A induces ROS-dependent apoptosis and suppresses STAT3 activation by direct binding in human lung cancer cells. J. Cancer, 11 : 3725-3735.
Lagorce D.,Douguet D.,Miteva M.A.,Villoutreix B.O. .2017 .Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci. Rep, 7 : 46277.
Lee G.R.,Won J.,Heo L.,Seok C. .2019 .Simultaneous refinement of inaccurate local regions and overall protein structure. Nucl. Acids Res, 47 : 451-455.
Lee S.,Hu L. .2020 .Nrf2 activation through the inhibition of Keap1-Nrf2 protein-protein interaction. Med. Chem. Res., 29 : 846-867.
Li Z.,Khan M.,Liu C.,Cui X.,Li Y. .2019 .Piceatannol inhibits akt activation, induces G2/M phase arrest and mitochondrial apoptosis and augments cisplatin eficacy in u2os osteosarcoma cells. Pakistan J. Zool, 51 : 2337-2344.
Liu L.,Chen X.,Yuan Y.,Hu Q.,Tang J.,Xie C. .2022 .Brevilin A ameliorates acute lung injury and inflammation through inhibition of NF-κB signaling via targeting IKKα/β. , 13 : 911157.
Liu M.,Lv J.,Chen L.,Li W.,W. W. .2022 .In silico discovery of anticancer peptides from Sanghuang. Int. J. mol. Sci, 23 : 13682.
Liu T.,Lv Y.F.,Zhao J.L.,You Q.D.,Jiang Z.Y. .2021 .Regulation of Nrf2 by phosphorylation: Consequences for biological function and therapeutic implications. Free Radic. Biol. Med, 03 : 129-141.
Madden S.K.,Itzhaki L.S. .2020 .Structural and mechanistic insights into the Keap1-Nrf2 system as a route to drug discovery. Biochim. Biophys. Acta Proteins Proteom, : .
Martínez L. .2015 .Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis. PLoS One, 10 : .
Maryam A.,Mehmood T.,Li H.,Khan Y.,M. Y. .2017 .Alantolactone induces apoptosis, promotes STAT3 glutathionylation and enhances chemosensitivity of A549 lung adenocarcinoma cells to doxorubicin via oxidative stress. Sci. Rep, 7 : 6242.
Meng M.,Tan J.,Chen H.,Shi Z.,Kwan Z.,Su T. .2023 .Brevilin A exerts anti-colorectal cancer efects and potently inhibits STAT3 signaling in vitro. Heliyon, 9 : .
Olasupo S.B.,Uzairu A.,Shallangwa G.,Uba S. .2020 .QSAR modeling, molecular docking and ADMET/pharmacokinetic studies: A chemometrics approach to search for novel inhibitors of norepinephrine transporter as potent antipsychotic drugs. J. Iran. Chem. Soc., 17 : 1953-1966.
Ooi B.K.,Chan K.G.,Goh B.H.,Yap W.H. .2018 .The role of natural products in targeting cardiovascular diseases via Nrf2 pathway: novel molecular mechanisms and therapeutic approaches. , 9 : 1308.
Padhi A.K.,Rath S.L.,Tripathi T. .2021 .Accelerating COVID-19 research using molecular dynamics simulation. J. Phys. Chem. B, 125 : 9078-9091.
Panieri E.,Saso L. .2019 .Potential applications of NRF2 inhibitors in cancer therapy. Oxid. Med, : .
Panieri E.,Buha A.,Telkoparan-Akillilar P.,Cevik D.,Kouretas D.,Veskoukis A.,Skaperda Z.,Tsatsakis A.,Wallace D.,Suzen S.,Saso L. .2020 .Potential applications of NRF2 modulators in cancer therapy. Antioxidants, 9 : 193.
Rajguru T.,Bora D.,Modi M.K. .2021 .Identification of promising inhibitors for Plasmodium haemoglobinase Falcipain-2, using virtual screening, molecular docking, and MD simulation. J. mol. Struct, 1248 : 131427.
Rizwana S.,Maqbool M.F.,Maryam A.,Bashir E.,Khan M.,Khan B.N.,Shakir H.A.,Irfan M. .2023 .Identification and characterization of sesquiterpene lactones as potential falcipain-2 inhibitors: Sesquiterpene lactones as potential falcipain-2 inhibitors. , : 901-21.
Saba A.,Sarwar F.,Muhammad S.,Ilyas M.,Iqbal J.,Al-Sehemi A.G.,Ayub K.,Gilani M.A.,Adnan M. .2022 .Insighting the inhibitory potential of novel modafinil drug derivatives against estrogen alpha (ERα) of breast cancer through a triple hybrid computational methodology. J. mol. Liq, 366 : 120234.
Saikat A.S.M.,Kabir M.L.,Khalipha A.B.R. .2020 .An in silico approach for structural and functional annotation of uncharacterized protein Rv0986 present in Mycobacterium tuberculosis. Eur. J. med. Hlth. Sci., 2 : 61-67.
Sajadimajd S.,Khazaei M. .2018 .Oxidative stress and cancer: The role of Nrf2. Curr. Cancer Drug Targets, 18 : 538-557.
Saleem M.Z.,Nisar M.A.,Alshwmi M.,Din S.R.U.,Gamallat Y.,Khan M. .2020 .Brevilin A inhibits STAT3 signaling and induces ROSDependent apoptosis, mitochondrial stress and endoplasmic reticulum stress in MCF-7 breast cancer cells. Oncol. Targets Ther, 13 : 435-450.
Su T.,Wang Y.P.,Wang X.N.,Li C.Y.,Zhu P.L.,Huang Y.M.,Yang Z.Y.,Chen S.B.,Yu Z.L. .2019 .The JAK2/STAT3 pathway is involved in the anti-melanoma efects of brevilin A. Life Sci. , 241 : 117169.
Telkoparan-Akillilar P.,Panieri E.,Cevik D.,Suzen S.,Saso L. .2021 .Therapeutic targeting of the NRF2 signaling pathway in cancer. Molecules, 26 : 1417.
Ulasov A.V.,Rosenkranz A.A.,Georgiev G.P.,Sobolev A.S. .2021 .Towards specific regulation. Life Sci, 291 : .
Wang J.,Li M.,Cui X.,Lv D.,Jin L.,Khan M. .2018 .Brevilin A promotes oxidative stress and induces mitochondrial apoptosis in U87 glioblastoma cells. Onco. Targets Ther, 11 : 7031-7040.
Xue D.,Zhou X. .2020 .EmergingroleofNRF2 in ROS-mediated tumor chemoresistance. Biomed, 13 : 110676.
You P.,Wu H.,Deng M.,Peng J.,Li F.,Yang Y. .2017 .Brevilin A induces apoptosis and autophagy of colon adenocarcinoma cell CT26 via mitochondrial pathway and PI3K/AKT/mTOR inactivation. , 12 : 619-625.
Zhang ,Xu H.X.,Zhu J.Q.,Dou Y.X.,Xian Y.F.,Lin Z.X. .2023 .Natural Nrf2 inhibitors: A review of their potential for cancer treatment. Int. J. biol. Sci., 19 : 3029.
Zhang X.,Xia Y.,Yang L.,He J.,Li Y.,Xia C. .2019 .Brevilin a, a sesquiterpene lactone, inhibits the replication of influenza a virus in vitro and in vivo. Viruses, 11 : 835.